Daniel Uslan

Dr. Daniel Z. Uslan has a longstanding interest in antibiotic utilization, benchmarking, and optimization. Dr. Uslan directs the antibiotic oversight program for the UCLA Health. His research is on antibiotic use, medical device infections including pacemaker infections, and epidemiology of infections. Dr. Uslan's clinical interests include bloodstream infections, surgical infections, endocarditis and other cardiovascular infections, and neurological infections. 

Dr. Uslan received his medical degree from University of Southern California in Los Angeles. He also earned an M.S. in Biotechnology from Northwestern University. Dr. Uslan completed his internship, residency, and Infectious Diseases fellowship at the Mayo Clinic in Rochester, MN. He is Board Certified in Internal Medicine and Infectious Diseases by the American Board of Internal Medicine and has numerous presentations and publications to his credit. Dr. Uslan was elected a Fellow of the Infectious Diseases Society of America in 2013. 

Education

  • MD, University of Southern California, Los Angeles, CA
  • MS, Biotechnology, Northwestern University, Evanston, IL
  • BS, Biology, University of California, San Diego, CA

Related Tags

Areas of Interest

  • Antimicrobial utilization, stewardship, and benchmarking
  • Novel infection control strategies including environmental approaches, cardiac and endovascular infections
  • Medical device infections
  • Surgical infections

Selected Publications

  • Frank PN, Palma Diaz MS, Uslan MD, Yeh MW. Histoplasmosis Mimicking Malignant Adenopathy During Diagnostic Thyroid Lobectomy. JAMA Otolaryngol Head Neck Surg. 2014 May 29. 
  • Greenspon, AJ, Le KY, Prutkin JM, Sohail MR, Vikram HR, Baddour LM, Danik SB, Peacok J, Falces C, Miro JM, Naber C, Carillo RG, Tseng CH, Uslan DZ. Influence of Vegetation Size on the Clinical Presentation and Outcomes of Lead-Associated Endocarditis: Results From the MEDIC Registry. 204 June 07. 
  • Dashiell-Earp CN, Bell DS, Ang AO, Uslan DZ. Do Physicians spend less tim with patients in contact isolation?: a time-motion study of internal medicine interns. JAMA Intern Med. 2014 May 17. 
  • Welch M, Uslan DZ, Greenspoon AJ, Sohail MR, Baddour LM, Blank E, Carillo RG, Danik SB, Del Rio A, Hellinger W, LE KY, Miro JM, Naber C, Peacock JE, Vikram HR, Tseng CH, Prutkin JM. Variability in Clinical Features of Early Virus Late Cardiovascular Implantable Electronic Device Pocket Infections. Pacing  Clin Electrophysiol. 2014 Mar 25. 
  • Stavrakis AL, Nikas JA, Shahbazian JH, Loftin AH, Ramos RI, Billi F, Francis KP, Otto M, Bernthal NM, Uslan DZ, Miller LS. Combination prophylactic therapy with rifampin increases efficacy agains an experimental Staphyloccus epidermidis subcutaneous implant-related infection. Antimicrob Agents Chemother. 2014 Apr. 
  • Kelesidis T, Humphries R, Chow AL, Tsiodras S, Uslan DZ. Emergence of daptomycin-non-susceptible enterococci tract isolates. J Med Microbiol. 2013 Jul. 
  • Humphries RM, Uslan DZ, Rubin Z. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratefied by patient disease severity. J Clinic Microbiol. 2013 Mar. 
  • Johnson SW, Kanatani M, Humphries RM, Uslan DZ. Clinical impact of switching conventional enzyme immunoassay with nucleic acid amplification test for suspected Clostridium difficile-associated diarrhea. Am J Infect Control. 2013 Apr.  
  • Le KY, Sohail MS, Friedman PA, Uslan DZ, Cha SS, Hayes DL, Wilson WR, Steckelberg JM, Baddour LM; Mayo Cardiovascular Infections Study Group. Clinical features and outcomes of cardiovascular implantable electronic device infections due to staphylococcal species. Am J Cardio. 2012 Oct 15.